Ginkgo Bioworks Patents

Patent portfolio assigned to Ginkgo Bioworks (verified via public assignee records). Public (NYSE: DNA) horizontal synthetic biology / cell-programming platform. Customers are biopharma/ag/food partners using its platform. Patents confirmed via Justia assignee page and Google Patents (e.g. US11274320B2); exact count not captured.